Original Medicare provides coverage for IV infusion therapy when a doctor determines it to be medically necessary, both in a clinic setting and at home. Medicare Advantage (Part C) plans need to offer ...

To ensure safety throughout the supply chain and in the patient’s home, providers are adopting tamper-evident products for intravenous home infusion. To better understand the steps home infusion ...

Every time Jenny publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

SOMERSET, Wis. (WCCO) — Home infusion is meant to help patients become independent and resume normal activities while recovering from an illness. The COVID-19 pandemic jump-started the growth of the ...

With hospitals around the nation facing unprecedented financial burden related to COVID-19, and more people becoming uninsured, it’s critical for healthcare leaders to identify sources of revenue and ...

The fear started when patients saw their nurses and dietitians posting job searches on LinkedIn. Word spread to Facebook groups, and patients started calling Coram CVS, a U.S. supplier of the ...

A new way to get vitamins is popping up all over Long Island — not from fruits and vegetables or pharmacies, but in sleek, spa-like venues where nurses pump nutrients from an IV bag directly into ...

SOUTH LAKE TAHOE, Calif. – Whether it was a long night out at the casinos at Stateline, a day spent on Lake Tahoe without drinking enough water, or simply just catching the common cold – experiencing ...

While Eli Lilly’s investigational monoclonal antibody drug, bamlanivimab, just received FDA emergency approval to treat mild coronavirus patients, top officials voiced concerns over its challenging IV ...

Ken Macon kicked his feet up on a recliner with a fur blanket in his Northeast Baltimore home as a doctor inserted a small needle into his arm. Macon had felt sluggish in the days leading up to his ...

The Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease, may be able to be given as a set of two weekly shots at home, a study from drugmaker Eisai suggests, ...

– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...